Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation

Neurosci Lett. 2014 Aug 22:578:117-21. doi: 10.1016/j.neulet.2014.06.041. Epub 2014 Jul 1.

Abstract

Stimulation of the protease-activated receptor 1 (PAR1) in vitro, was shown to induce synaptic retrograde signaling through the endocannabinoid 2-arachidonoylglycerol (2-AG) synthesis and activation of the cannabinoid receptor type 1 (CB1R). The activation of PAR1 by the agonist S1820 in the lateral hypothalamus (LH) increases rapid eye movement sleep (REMS) and food intake in rats, and both effects are prevented by the CB1R inverse agonist AM251. In the present study, we implanted rats with electrodes and with cannulae aimed bilaterally to the LH. We administered tetrahydrolipstatin (THL), an inhibitor of the diacylglycerol lipase (DAGL), the enzyme responsible for 2-AG synthesis, to evaluate the sleep-wake cycle and food ingestion. THL in the LH readily prevented the increase in REMS and food intake induced by PAR1 stimulation, further supporting 2-AG as an upstream activator of PAR1. Our results demonstrate that the effect of PAR1 on REMS and food intake is blocked by the inhibition of DAGL, further suggesting that PAR1 stimulation in the lateral hypothalamus of rats induces an increase in sleep and food intake through 2-AG.

Keywords: 2-Arachidonoylglycerol; Cannabinoid receptor type 1; Food intake; Protease-activated receptor 1; Rapid eye movement sleep; Tetrahydrolipstatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Eating / drug effects
  • Eating / physiology*
  • Enzyme Inhibitors / pharmacology
  • Hypothalamic Area, Lateral / enzymology*
  • Lactones / pharmacology
  • Lipoprotein Lipase / antagonists & inhibitors
  • Lipoprotein Lipase / metabolism*
  • Male
  • Orlistat
  • Rats
  • Rats, Wistar
  • Receptor, PAR-1 / agonists
  • Receptor, PAR-1 / metabolism*
  • Signal Transduction
  • Sleep, REM / drug effects
  • Sleep, REM / physiology*

Substances

  • Enzyme Inhibitors
  • Lactones
  • Receptor, PAR-1
  • Orlistat
  • Lipoprotein Lipase